Ligand based on pyridine structure and preparation method thereof, and supported catalyst based on pyridine structure and preparation method and application thereof
A technology of pyridine and ligands, which is applied in ethylene oligomerization, preparation, ligands based on pyridine structure and its preparation, and the field of supported catalysts based on pyridine structure, which can solve the problems of difficult equipment blockage and avoid equipment blockage , high target product selectivity, and the effect of reducing the probability of clogged pipelines
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0086] Example 1
[0087] The preparation method of ligand (L1):
[0088] 1) The 2,6-dibromo-4-methylpyridine (105.5 mmol) and aqueous methamide (211 mmol) were first heated at 180 ° C for 5 h, and then filtered, water (400 mL) and dichloromethane were added to the filtrate. 200 mL) EtOAc (EtOAc) EtOAc (EtOAc) EtOAc (EtOAc) The mixed solvent was allowed to give the product.
[0089] The product (80 mmol) was dissolved in acetonitrile (100 mL) solvent, then n-butyl lithium (160 mmol) was added at -80 ° C, and the reaction was added to -5 ° C, and the temperature was added to -5 ° C. 1H, the reaction liquid was purified by the column chromatography (a high diameter ratio of 2, the residence time was 2 min), and the mixed solvent of ethyl acetate and n-hexane of 1: 1 were dried, and the ligand L1 was obtained.
[0090]
[0091] The core magnetic data of the ligand (L1) is as follows: 1H NMR (400 MHz, CDCl3): 7.35 ~ 7.42 (m, 20H), 5.74 (S, 2H), 2.36 (S, 3H).
[0092] 2) At a nitroge...
Example Embodiment
[0095] Example 2
[0096] The kit (L2) is different from the preparation method in Example 1 in:
[0097]1) The 2,6-dibromo-4-methylpyridine (105.5 mmol) and isopropylamine (232.1 mmol) were first heated at 185 ° C for 6 h, and then filtered, water (600 ml) and dichloromethane were added to the filtrate. 200 mL) EtOAc (EtOAc) EtOAc (EtOAc) EtOAc (EtOAc) The mixed solvent was allowed to give the product.
[0098] The product was dissolved in acetonitrile (80 mmol) solvent, then n-butyl lithium (176 mmol) was added at -75 ° C, and the reaction was added to -3 ° C. After the temperature was added to -3 ° C, then the diphenylphosphine (176 mmol) was added, and the reaction was 2 h, the reaction The liquid was purified by the column chromatography (a high diameter ratio of 2, the residence time was 2 min) purified, and the mixed solvent of ethyl acetate and n-hexane of 1: 1 was dried, and the ligand L2 was obtained.
[0099]
[0100] The nuclear magnetic data of the above ligand (L2)...
Example Embodiment
[0104] Example 3
[0105] The preparation method of the ligand (L3) and the first embodiment is to:
[0106] 1) First, 2,6-dibromo-4-methylpyridine (105.5 mmol) and tert-butlamine (263.8 mmol) were heated at 190 ° C for 8 h, and then filtered, water (800 ml) and dichloromethane were added to the filtrate (200ml Extraction, vacuum conditions were removed to remove dichloromethane, and the resulting product was column chromatography (high diameter ratio of 2, the residence time was purified), and the magazine phase was 1: 1 of ethyl acetate and n-hexane. The mixed solvent was dried.
[0107] The product was dissolved in acetonitrile (80 mmol) solvent, then n-butyl lithium (192 mmol) was added at -70 ° C, and the reaction was added to 0 ° C, and the reaction was added to 0 ° C. The column chromatography (a high diameter ratio of 2, the residence time was 2 min) purified, the mixed solvent of ethyl acetate and n-hexane of 1: 1, and the ligand L3 was obtained after drying.
[0108]
...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap